{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:12:12Z","timestamp":1761581532123,"version":"3.41.2"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T00:00:00Z","timestamp":1488585600000},"content-version":"vor","delay-in-days":62,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100015158","name":"Fondren Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015158","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Public Health Ontario","award":["PIF-2015-007"],"award-info":[{"award-number":["PIF-2015-007"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Invasive group A Streptococcus (iGAS) disease caused by type emm89 strains has been increasing worldwide, driven by the emergence of an epidemic clonal variant (clade 3 emm89). The clinical characteristics of patients with emm89 iGAS disease, and in particular with clade 3 emm89 iGAS disease, are poorly described.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used population-based iGAS surveillance data collected in metropolitan Toronto, Ontario, Canada during the period 2000\u20132014. We sequenced the genomes of 105 emm89 isolates representing all emm89 iGAS disease cases in the area during the period and 138 temporally matched emm89 iGAS isolates collected elsewhere in Ontario.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Clades 1 and 2 and clade O, a newly discovered emm89 genetic variant, caused most cases of emm89 iGAS disease in metropolitan Toronto before 2008. After rapid emergence of new clade 3, previously circulating clades were purged from the population and the incidence of emm89 iGAS disease significantly increased from 0.14 per 100000 in 2000\u20132007 to 0.22 per 100000 in 2008\u20132014. Overall, emm89 organisms caused significantly more arthritis but less necrotizing fasciitis than strains of the more common type emm1. Other clinical presentations were soft tissue and severe respiratory tract infections. Clinical outcomes did not differ significantly between emm89 clades overall. However, clade 3 emm89 iGAS disease was more common in youth and middle-aged individuals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The rapid shift in emm89 iGAS strain genetics in metropolitan Toronto has resulted in a significant increase in the incidence of emm89 iGAS disease, with noticeably higher rates of clade 3 disease in younger patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofx042","type":"journal-article","created":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T13:53:54Z","timestamp":1488635634000},"source":"Crossref","is-referenced-by-count":5,"title":["Rapid Emergence of a New Clone Impacts the Population at Risk and Increases the Incidence of Type emm89 Group A Streptococcus Invasive Disease"],"prefix":"10.1093","volume":"4","author":[{"given":"Sarah","family":"Teatero","sequence":"first","affiliation":[{"name":"Public Health Ontario, Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda L.","family":"Coleman","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada"},{"name":"Mount Sinai Hospital, Toronto, Canada; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Beres","sequence":"additional","affiliation":[{"name":"Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall J.","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Kandel","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada"},{"name":"Mount Sinai Hospital, Toronto, Canada; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Public Health Ontario, Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taryn B. T.","family":"Athey","sequence":"additional","affiliation":[{"name":"Public Health Ontario, Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Musser","sequence":"additional","affiliation":[{"name":"Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"McGeer","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada"},{"name":"Mount Sinai Hospital, Toronto, Canada; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahuel","family":"Fittipaldi","sequence":"additional","affiliation":[{"name":"Public Health Ontario, Toronto, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,3,4]]},"reference":[{"key":"2020081005074021200_CIT0001","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrmicro2648","article-title":"Molecular insight into invasive group A streptococcal disease","volume":"9","author":"Cole","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"2020081005074021200_CIT0002","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jama.1993.03500030082037","article-title":"The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study","volume":"269","author":"Hoge","year":"1993","journal-title":"JAMA"},{"key":"2020081005074021200_CIT0003","first-page":"1","article-title":"Group a streptococcal diseases and their global burden","volume":"368","author":"Ralph","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"2020081005074021200_CIT0004","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1469-0691.2005.01345.x","article-title":"Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region","volume":"12","author":"Laupland","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"2020081005074021200_CIT0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.47.1.91","article-title":"The antigenic complex of Streptococcus haemolyticus: I. Demonstration of a type-specific substance in extracts of Streptococcus haemolyticus","volume":"47","author":"Lancefield","year":"1928","journal-title":"J Exp Med"},{"key":"2020081005074021200_CIT0006","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1073\/pnas.82.6.1822","article-title":"Relationship of M protein genes in group A streptococci","volume":"82","author":"Scott","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020081005074021200_CIT0007","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.163.1.129","article-title":"Antigenic domains of the streptococcal Pep M5 protein. Localization of epitopes crossreactive with type 6 M protein and identification of a hypervariable region of the M molecule","volume":"163","author":"Manjula","year":"1986","journal-title":"J Exp Med"},{"key":"2020081005074021200_CIT0008","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.00101-13","article-title":"Disease manifestations and pathogenic mechanisms of group A Streptococcus","volume":"27","author":"Walker","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2020081005074021200_CIT0009","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","article-title":"Global emm type distribution of group A streptococci: systematic review and implications for vaccine development","volume":"9","author":"Steer","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"2020081005074021200_CIT0010","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1586\/erv.09.133","article-title":"Differences among group A Streptococcus epidemiological landscapes: consequences for M protein-based vaccines?","volume":"8","author":"Smeesters","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"2020081005074021200_CIT0011","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1172\/JCI38095","article-title":"A decade of molecular pathogenomic analysis of group A Streptococcus","volume":"119","author":"Musser","year":"2009","journal-title":"J Clin Invest"},{"key":"2020081005074021200_CIT0012","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1172\/JCI45169","article-title":"Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice","volume":"121","author":"Carroll","year":"2011","journal-title":"J Clin Invest"},{"key":"2020081005074021200_CIT0013","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1073\/pnas.0911811107","article-title":"Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis","volume":"107","author":"Olsen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020081005074021200_CIT0014","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.meegid.2014.10.011","article-title":"Molecular epidemiology and genomics of group A Streptococcus","volume":"33","author":"Bessen","year":"2015","journal-title":"Infect Genet Evol"},{"key":"2020081005074021200_CIT0015","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00403-16","article-title":"Transcriptome remodeling contributes to epidemic disease caused by the human pathogen Streptococcus pyogenes","volume":"7","author":"Beres","year":"2016","journal-title":"MBio"},{"key":"2020081005074021200_CIT0016","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1172\/JCI82478","article-title":"A molecular trigger for intercontinental epidemics of group A Streptococcus","volume":"125","author":"Zhu","year":"2015","journal-title":"J Clin Invest"},{"key":"2020081005074021200_CIT0017","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1073\/pnas.1403138111","article-title":"Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3615 genome sequences","volume":"111","author":"Nasser","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020081005074021200_CIT0018","doi-asserted-by":"crossref","first-page":"e00622","DOI":"10.1128\/mBio.00622-15","article-title":"Emergence of a new highly successful acapsular group a Streptococcus clade of genotype emm89 in the United Kingdom","volume":"6","author":"Turner","year":"2015","journal-title":"MBio"},{"key":"2020081005074021200_CIT0019","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1017\/S0950268814001265","article-title":"Increased prevalence of group A Streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012","volume":"143","author":"Ikebe","year":"2015","journal-title":"Epidemiol Infect"},{"key":"2020081005074021200_CIT0020","doi-asserted-by":"crossref","first-page":"e01780","DOI":"10.1128\/mBio.01780-15","article-title":"Emergence of the same successful clade among distinct populations of emm89 Streptococcus pyogenes in multiple geographic regions","volume":"6","author":"Fri\u00e3es","year":"2015","journal-title":"MBio"},{"key":"2020081005074021200_CIT0021","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3201\/eid1711.110159","article-title":"Group A Streptococcusemm gene types in pharyngeal isolates, Ontario, Canada, 2002\u20132010","volume":"17","author":"Shea","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"2020081005074021200_CIT0022","doi-asserted-by":"crossref","first-page":"e01378","DOI":"10.1128\/mBio.01378-15","article-title":"Trading capsule for increased cytotoxin production: contribution to virulence of a newly emerged clade of emm89 Streptococcus pyogenes","volume":"6","author":"Zhu","year":"2015","journal-title":"MBio"},{"key":"2020081005074021200_CIT0023","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1128\/JCM.02155-08","article-title":"Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe","volume":"47","author":"Luca-Harari","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2020081005074021200_CIT0024","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/0036554021000026944","article-title":"Primary group A streptococcal peritonitis in a previously healthy child","volume":"34","author":"Gillespie","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"2020081005074021200_CIT0025","first-page":"179","article-title":"Evaluation of gastrointestinal symptoms as primary sign of severe invasive group A streptococcal infections","volume":"119","author":"Ekelund","year":"2004","journal-title":"Indian J Med Res"},{"key":"2020081005074021200_CIT0026","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1469-0691.2011.03624.x","article-title":"Invasive group A streptococcal infections in adults, France (2006\u20132010)","volume":"18","author":"Plainvert","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2020081005074021200_CIT0027","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1056\/NEJM199608223350803","article-title":"Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group","volume":"335","author":"Davies","year":"1996","journal-title":"N Engl J Med"},{"key":"2020081005074021200_CIT0028","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections","volume":"269","year":"1993","journal-title":"JAMA"},{"key":"2020081005074021200_CIT0029","first-page":"238","article-title":"Streptococcus and related catalase-negative Gram-positive cocci","volume-title":"Shadomy Manual of Clinical Microbiology","author":"Facklam","year":"1991","edition":"5th ed"},{"key":"2020081005074021200_CIT0030","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1099\/00221287-146-5-1195","article-title":"emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci","volume":"146","author":"Beall","year":"2000","journal-title":"Microbiology"},{"key":"2020081005074021200_CIT0031","doi-asserted-by":"crossref","first-page":"e00413-12","DOI":"10.1128\/mBio.00413-12","article-title":"Human disease isolates of serotype M4 and M22 group a streptococcus lack genes required for hyaluronic acid capsule biosynthesis","volume":"3","author":"Flores","year":"2012","journal-title":"MBio"},{"key":"2020081005074021200_CIT0032","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/infdis\/jiw468","article-title":"Genomic tracks behind spread of bacteremic Group A Streptococcus type emm89 in Finland, 2004\u20132014","volume":"214","author":"Latronico","year":"2016","journal-title":"J Infect Dis"},{"key":"2020081005074021200_CIT0033","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2807\/1560-7917.ES2014.19.17.20784","article-title":"Invasive infections due to Streptococcus pyogenes: seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012","volume":"19","author":"Olafsdottir","year":"2014","journal-title":"Euro Surveill"},{"key":"2020081005074021200_CIT0034","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/cid\/ciw248","article-title":"Epidemiology of invasive group A streptococcal infections in the United States, 2005\u20132012","volume":"63","author":"Nelson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020081005074021200_CIT0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/JCM.02201-15","article-title":"High incidence of invasive group A Streptococcus disease caused by strains of uncommon emm types in Thunder Bay, Ontario, Canada","volume":"54","author":"Athey","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2020081005074021200_CIT0036","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.ajpath.2011.12.037","article-title":"Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group A Streptococcus","volume":"180","author":"Fittipaldi","year":"2012","journal-title":"Am J Pathol"},{"key":"2020081005074021200_CIT0037","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/infdis\/jiw468","article-title":"Genomic tracks behind spread of bacteremic group A Streptococcus type emm89 in Finland, 2004\u20132014","volume":"214","author":"Latronico","year":"2016","journal-title":"J Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/4\/2\/ofx042\/33605072\/ofx042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/4\/2\/ofx042\/33605072\/ofx042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T09:09:52Z","timestamp":1597050592000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofx042\/3061964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofx042","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2017]]},"published":{"date-parts":[[2017]]},"article-number":"ofx042"}}